SCHEMBL7334180

SCHEMBL7334180

CCCN(CCC)C1CCc2c(cccc2N(C)Cc2ccccc2)C1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 12/20 0.67
DRD3 P35462 7/20 0.67
DRD4 P21917 5/20 0.62
DRD1 P21728 4/20 0.62
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2D6 P10635 1/20 0.62
TSHR P16473 1/20 0.62
NFKB1 P19838 1/20 0.62
THPO P40225 1/20 0.62
HTR1A P08908 4/20 0.62
HTR7 P34969 4/20 0.62
LMNA P02545 1/20 0.61
PMP22 Q01453 1/20 0.61
DRD5 P21918 1/20 0.59
ADRB2 P07550 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7334103 0.87 DRD2 (0.66) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7331703 0.84 DRD2 (0.61) DRD2DRD3DRD4DRD1CYP1A2
Hydrochloric Acid SCHEMBL7336566 0.79 DRD2 (0.66) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL7327849 0.79 DRD2 (0.59) DRD2DRD3DRD4DRD1CYP1A2
SCHEMBL7335087 0.78 DRD2 (0.64) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL30350387 0.77 DRD2 (1.00) DRD2DRD3DRD4DRD1CYP1A2
SCHEMBL7382314 0.77 DRD2 (1.00) DRD2DRD3DRD4DRD1CYP1A2
SCHEMBL26690439 0.77 HTR7 (1.00) DRD2DRD3DRD4DRD1HTR1A
SCHEMBL8672358 0.76 HTR1A (0.56) DRD2DRD3CYP1A2CYP2D6TSHR
Hydrochloric Acid SCHEMBL7327809 0.76 DRD2 (0.76) DRD2DRD3DRD4DRD1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5233052-A Insecticidal and acaricidal diarylpyrrolecarbonitrile and diarylnitropyrrole compounds AMERICAN CYANAMID COMPANY (US) 1993-08-03 US disclosed
US-5196454-A METHOD OF TREATING DISORDERS OF THE DOPAMINERGIC SYSTEMS USING 2,5-DIAMINOTETRALINES BOEHRINGER INGELHEIM KG (DE) 1993-03-23 US disclosed
EP-0402923-A2 2,5-Diaminotetralines, process for their preparation and their use as medicine BOEHRINGER INGELHEIM KG (DE) 1990-12-19 EP disclosed